"Heptanoic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
7-carbon saturated monocarboxylic acids.
| Descriptor ID |
D006538
|
| MeSH Number(s) |
D10.251.450
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heptanoic Acids".
Below are MeSH descriptors whose meaning is more specific than "Heptanoic Acids".
This graph shows the total number of publications written about "Heptanoic Acids" by people in this website by year, and whether "Heptanoic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 8 | 2 | 10 |
| 2004 | 2 | 1 | 3 |
| 2005 | 6 | 0 | 6 |
| 2006 | 6 | 1 | 7 |
| 2007 | 6 | 2 | 8 |
| 2008 | 6 | 5 | 11 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 4 | 2 | 6 |
| 2012 | 4 | 1 | 5 |
| 2013 | 6 | 2 | 8 |
| 2014 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heptanoic Acids" by people in Profiles.
-
Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin. Arterioscler Thromb Vasc Biol. 2014 Nov; 34(11):2465-72.
-
High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care. 2014 Nov; 37(11):3114-20.
-
Inflammatory stress reduces the effectiveness of statins in the kidney by disrupting HMGCoA reductase feedback regulation. Nephrol Dial Transplant. 2014 Oct; 29(10):1864-78.
-
Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST). Arterioscler Thromb Vasc Biol. 2014 Jun; 34(6):1298-306.
-
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med. 2014 May 08; 370(19):1809-19.
-
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. Eur Heart J Cardiovasc Imaging. 2014 Apr; 15(4):380-8.
-
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. JAMA. 2014 Jan 15; 311(3):252-62.
-
Leveraging electronic health records to notify pediatric patients of a drug recall. JAMA Pediatr. 2013 Dec; 167(12):1170-1.
-
Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation. Arterioscler Thromb Vasc Biol. 2014 Feb; 34(2):365-76.
-
Influence of PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms on the lipid-lowering efficacy and safety of statin therapy. Arq Bras Endocrinol Metabol. 2013 Oct; 57(7):513-9.